<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<headerData>
<submissionType>144</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001824542</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>
</filerInfo>
</headerData>
<formData>
<issuerInfo>
<issuerCik>0001818794</issuerCik>
<issuerName>Dyne Therapeutics, Inc.</issuerName>
<secFileNumber>001-39509</secFileNumber>
<issuerAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">1560 Trapelo Road</street1>
<city xmlns="http://www.sec.gov/edgar/common">Waltham</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">02451</zipCode>
</issuerAddress>
<issuerContactPhone>(781)-786-8230</issuerContactPhone>
<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Oxana Beskrovnaya</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
<relationshipsToIssuer>
<relationshipToIssuer>Officer</relationshipToIssuer>
</relationshipsToIssuer>
</issuerInfo>
<securitiesInformation>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>Stifel Financial Corporation</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">3 Bryant Park, 4th Floor</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">1095 Avenue of the Americas</street2>
<city xmlns="http://www.sec.gov/edgar/common">New York</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">NY</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">10036</zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>45326</noOfUnitsSold>
<aggregateMarketValue>860378</aggregateMarketValue>
<noOfUnitsOutstanding>61375598</noOfUnitsOutstanding>
<approxSaleDate>01/03/2024</approxSaleDate>
<securitiesExchangeName>NASDAQ</securitiesExchangeName>
</securitiesInformation>
<securitiesToBeSold>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<acquiredDate>01/03/2024</acquiredDate>
<natureOfAcquisitionTransaction>Stock option exercise</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>45326</amountOfSecuritiesAcquired>
<paymentDate>01/03/2024</paymentDate>
<natureOfPayment>Cash</natureOfPayment>
</securitiesToBeSold>
<nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
<securitiesSoldInPast3Months>
<sellerDetails>
<name>Oxana Beskrovnaya</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">1560 Trapelo Road</street1>
<city xmlns="http://www.sec.gov/edgar/common">Waltham</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">02451</zipCode>
</address>
</sellerDetails>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<saleDate>12/11/2023</saleDate>
<amountOfSecuritiesSold>1467</amountOfSecuritiesSold>
<grossProceeds>15726</grossProceeds>
</securitiesSoldInPast3Months>
<remarks>The sales reported in this Form 144 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2023. Securities sold on December 11, 2023 represent shares sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 10, 2021 and December 9, 2022.</remarks>
<noticeSignature>
<noticeDate>01/03/2024</noticeDate>
<planAdoptionDates>
<planAdoptionDate>06/30/2023</planAdoptionDate>
</planAdoptionDates>
<signature>/s/ Richard Scalzo, Attorney-in-Fact</signature>
</noticeSignature>
</formData>
</edgarSubmission>
